Filing Details
Galera Therapeutics, Inc. (OTC:GRTX) filed a Form 8-K with the Securities and Exchange Commission on July 07, 2026, disclosing a material event.
8k filedOTC:GRTX
Galera Therapeutics, Inc. (GRTX) Reports Material Event to SEC
Filing Details Galera Therapeutics, Inc. (OTC:GRTX) filed a Form 8-K with the Securities and Exchange Commission on July 07, 2026, disclosing a material event. Market Context…
Market Context
Galera Therapeutics, Inc.'s stock currently trades at $0.09 with a market capitalization of $1.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Galera Therapeutics, Inc.'s stock.
All SEC filings for Galera Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GRTX Stock Page
Frequently Asked Questions
Where can I read GRTX's SEC filings?
Browse all filings on our GRTX SEC filings page.
What types of SEC filings does Galera Therapeutics, Inc. file?
Public companies like Galera Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.